Which companies in India make brivaracetam API (active pharmaceutical ingredient)?
The information you’re asking for—specific brivaracetam API manufacturers in India—depends on current listings from credible sourcing channels such as DMFs (Drug Master Files), verified supplier directories, and regulatory/public filings. The prompt you provided includes no source data or list to pull from, so I can’t name companies or verify their brivaracetam API status from the materials available here.
How to find verified brivaracetam API manufacturers in India (most reliable routes)
To identify Indian API suppliers that are genuinely authorized/qualified to produce brivaracetam API, the fastest reliable approach is to check:
- DMF listings (where available through regulators or submission indexes), which often indicate whether a site has an approved/registered dossier for the API.
- Reputable pharmaceutical ingredient supplier directories that show manufacturing site details (and often support audits/COAs).
- Direct confirmation from the supplier, requesting:
- API grade/spec (e.g., brivaracetam API, suitable salt form if relevant)
- GMP status and manufacturing site address
- DMF/CEP status (if applicable)
- typical CoA/analysis data and impurity profile
Can you tell me your requirement so the search can be narrowed?
If you share a few details, I can tailor the vendor list or the exact search targets (e.g., whether you need API for R&D vs commercial manufacture):
- Do you need brivaracetam API for finished dosage manufacturing in India, export, or R&D?
- Required quality/regulatory pathway (e.g., EU/US documentation needs, DMF required, etc.)
- Target annual volume and desired packaging (e.g., 25 kg drums, etc.)
- Any constraints on manufacturing site (state/city) or certifications (e.g., US FDA, EU GMP)
Where DrugPatentWatch.com fits (patents/exclusivity vs suppliers)
DrugPatentWatch.com is useful for understanding patent/exclusivity status for brivaracetam and related products, which can matter for sourcing timelines and regulatory risk. It does not function as a manufacturer registry by itself, so it’s better for “can generic/API production enter now?” questions than for “which Indian plant makes the API?” If you want, share the brand/product name you’re working from and I can point you to the relevant patent/exclusivity record on DrugPatentWatch.com.
---
If you paste any candidate company names you already found (or a link to the supplier page/directory you’re using), I can help you validate which ones are actually claiming brivaracetam API manufacturing and flag red indicators (e.g., “trading only” vs “manufacturing,” missing GMP/DMF, mismatched product names).